Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others. Economy Entrepreneurship Finance'

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. The translation involves people and processes.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. The hope was that the diversity of brainpower and perspectives would yield imaginative ways to outgrow the shortfall. What’s needed is a way to enhance, even exploit, the value of the diversity in the room.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. competitiveness and growth in the 21 st century.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. The course culminates in a team-based innovation project presented to hospital leadership. These challenges require extraordinary leaders.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

MARCH 9, 2015

Advances in digital technology and their use in organizations carry huge promise to empower people at all levels. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S. Leadership & Managing people Technology Managing yourself'

Tools 8

Tools CEO Mezzanine Software 8

Strategy Driven

MARCH 18, 2011

Large downturns (such as this recession), technology disruptions, or regulatory shifts create discontinuities that simply accelerate the industry’s evolution toward this equilibrium state. Finally, many industries are responding to the pressures of the last few years by differentiating themselves.

Resources 52

Resources Industry System Strategy 52

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

MARCH 8, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. In a world with severe healthcare resource constraints, mobile digital technology can be a major " force multiplier." There are now more than 5.3

Wireless 15

Wireless Health Care Pharmaceuticals Business Model 15

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. In fact, in two practices in particular — "firing" and "leveraging diversity" — many companies fail dismally. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. My favorite example of this is iRobot , the maker of the innovative Roomba vacuum.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

JUNE 24, 2015

The f ive forces framework for strategy may be valid in one arena, blue ocean or open innovation in another, but each approach to strategy tends to be presented or perceived as a panacea. A firm can be the first to apply a new technology or to identify and address a major source of customer dissatisfaction or a latent need.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

MARCH 8, 2011

Lafley became the CEO of Procter & Gamble, he saw that the company's current expansion strategy, which had put it in markets as diverse as pharmaceuticals and snack foods, would continue to erode value.

Merchandising 14

Merchandising Budgeting Pharmaceuticals CEO 14

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 13

Innovation Productivity Products Venture Capitalist 13